Cabozanib™ is a quality-assured generic of Cabometyx® which is used to treat advanced renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC) in patients who were previously treated with sorafenib. It’s also used to treat differentiated thyroid cancer (DTC) that has progressed after VEGFR-targeted treatment in patients who can no longer be treated with radioactive iodine.
Cabozantinib – Cabozanib 20 Mg
Bottle Size: 30 Tablets
Active Ingredients: Cabozantinib 20 MG
Produced by BDR Pharmaceuticals Ltd®